Revascularization treatment in patients with coronary artery disease

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Cardiac Surgery

Background:

• Advances in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) complicate optimal revascularization strategy selection for coronary artery disease (CAD).
• Drug-eluting stents (DES) mitigate restenosis concerns associated with earlier stent technologies, while off-pump and minimally invasive CABG offer safer alternatives to traditional surgery.

Purpose of the Study:

• To address the ongoing dilemma in selecting the optimal revascularization strategy for patients with coronary artery disease (CAD).
• To evaluate the efficacy of contemporary PCI with DES versus modern CABG techniques, particularly in high-risk populations like diabetics and those with chronic kidney disease.

Main Methods:

• Review of existing literature on PCI and CABG for CAD.
• Acknowledgement of ongoing clinical trials designed for head-to-head comparisons between DES-assisted PCI and contemporary bypass surgery.

Main Results:

• Current literature may not reflect the latest advancements in PCI (DES) and CABG (off-pump, minimally invasive).
• The optimal revascularization strategy remains debated, especially for high-risk CAD patient subgroups.

Conclusions:

• Head-to-head trials are crucial to definitively compare DES-assisted PCI and contemporary CABG.
• Evidence from ongoing trials is anticipated to resolve the debate on the best revascularization strategy for diverse CAD patient populations.